Besnard M - Search Results

1

Novel polyester-polysaccharide nanoparticles.

Lemarchand C, Couvreur P, Besnard M, Costantini D, Gref R. Lemarchand C, et al. Among authors: besnard m. Pharm Res. 2003 Aug;20(8):1284-92. doi: 10.1023/a:1025017502379. Pharm Res. 2003. PMID: 12948027

2

The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers.

Brigger I, Armand-Lefevre L, Chaminade P, Besnard M, Rigaldie Y, Largeteau A, Andremont A, Grislain L, Demazeau G, Couvreur P. Brigger I, et al. Among authors: besnard m. Pharm Res. 2003 Apr;20(4):674-83. doi: 10.1023/a:1023267304096. Pharm Res. 2003. PMID: 12739778

3

Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules.

Hillaireau H, Le Doan T, Besnard M, Chacun H, Janin J, Couvreur P. Hillaireau H, et al. Among authors: besnard m. Int J Pharm. 2006 Oct 31;324(1):37-42. doi: 10.1016/j.ijpharm.2006.07.006. Epub 2006 Jul 10. Int J Pharm. 2006. PMID: 16935444

4

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.

Peracchia MT, Fattal E, Desmaële D, Besnard M, Noël JP, Gomis JM, Appel M, d'Angelo J, Couvreur P. Peracchia MT, et al. Among authors: besnard m. J Control Release. 1999 Jun 28;60(1):121-8. doi: 10.1016/s0168-3659(99)00063-2. J Control Release. 1999. PMID: 10370176

5

Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route.

Lalanne M, Andrieux K, Paci A, Besnard M, Ré M, Bourgaux C, Ollivon M, Desmaele D, Couvreur P. Lalanne M, et al. Among authors: besnard m. Int J Pharm. 2007 Nov 1;344(1-2):62-70. doi: 10.1016/j.ijpharm.2007.05.064. Epub 2007 Jun 3. Int J Pharm. 2007. PMID: 17616448

6

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation.

Brigger I, Chaminade P, Marsaud V, Appel M, Besnard M, Gurny R, Renoir M, Couvreur P. Brigger I, et al. Among authors: besnard m. Int J Pharm. 2001 Feb 19;214(1-2):37-42. doi: 10.1016/s0378-5173(00)00628-1. Int J Pharm. 2001. PMID: 11282234

7

Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice.

Reddy LH, Khoury H, Paci A, Deroussent A, Ferreira H, Dubernet C, Declèves X, Besnard M, Chacun H, Lepêtre-Mouelhi S, Desmaële D, Rousseau B, Laugier C, Cintrat JC, Vassal G, Couvreur P. Reddy LH, et al. Among authors: besnard m. Drug Metab Dispos. 2008 Aug;36(8):1570-7. doi: 10.1124/dmd.108.020735. Epub 2008 May 12. Drug Metab Dispos. 2008. PMID: 18474674

8

Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

Shakweh M, Besnard M, Nicolas V, Fattal E. Shakweh M, et al. Among authors: besnard m. Eur J Pharm Biopharm. 2005 Sep;61(1-2):1-13. doi: 10.1016/j.ejpb.2005.04.006. Eur J Pharm Biopharm. 2005. PMID: 16005619

9

Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.

Cournarie F, Chéron M, Besnard M, Vauthier C. Cournarie F, et al. Among authors: besnard m. Eur J Pharm Biopharm. 2004 Mar;57(2):171-9. doi: 10.1016/S0939-6411(03)00191-7. Eur J Pharm Biopharm. 2004. PMID: 15018972

10

Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

Gómez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E. Gómez-Gaete C, et al. Among authors: besnard m. Int J Pharm. 2007 Mar 1;331(2):153-9. doi: 10.1016/j.ijpharm.2006.11.028. Epub 2006 Nov 12. Int J Pharm. 2007. PMID: 17157461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page